Merck starts commercial production of first GMP-compliant manufacturing line for cell culture media in China
€ 6.6 million investment at Nantong site expands production capabilities for cell culture media
€ 6.6 million investment at Nantong site expands production capabilities for cell culture media
Acquisition strengthens and diversifies Merck’s pipeline with the addition of Restoret
The facility is a part of Lupin Manufacturing Solutions
The approved ANDA is therapeutically equivalent to the reference listed drug product
Dr. Roopal Thakkar joined Abbott/AbbVie in 2003 as part of the Physician Development Program
Olverembatinib, a novel drug developed by Ascentage Pharma with support from the National Major New Drug Development program
Utidelone can penetrate BBB due to its unique physicochemical characteristics and insusceptibility to P-glycoprotein-mediated efflux
Acquisition provides Ligand with the royalty rights to QARZIBA, a highly differentiated, commercial oncology drug marketed in 35 countries by global pharmaceutical company Recordati S.p.A.
The academy has secured partnerships with 15 esteemed hospitals
Achievement of This Major Milestone Further Simplifies and Strengthens the Company and Positions Viatris to Achieve its Key Priorities and Accelerate Future Growth
Subscribe To Our Newsletter & Stay Updated